4.7 Article

An electrochemical biosensor for PD-L1 positive exosomes based on ultra-thin two-dimensional covalent organic framework nanosheets coupled with CRISPR-Cas12a mediated signal amplification

期刊

SENSORS AND ACTUATORS B-CHEMICAL
卷 362, 期 -, 页码 -

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.snb.2022.131813

关键词

Electrochemical biosensor; Covalent organic frameworks; PD-L1(+) exosomes; CRISPR-Cas 12a

资金

  1. National Natural Science Foundation of China [81772593]
  2. Fundamental Research Funds for the Central Universities [14380163]

向作者/读者索取更多资源

This study presents an electrochemical biosensor based on 2D COF NSs and CRISPR Cas 12a for the detection of PD-L1(+) exosomes. The sensor shows high sensitivity and a wide linear range, and can be used for clinical diagnosis.
Programmed death-ligand 1 protein positive (PD-L1(+)) exosome is one of the most prospective biomarkers for the diagnosis of cancer. However, the current methods for the detection of PD-L1(+) exosomes are usually laborious, time-consuming and require numerous samples. Herein, we report in this paper an electrochemical biosensor for PD-L1(+) exosomes detection based on ultra-thin two-dimensional covalent organic framework nanosheets (2D COF NSs) coupled with clustered regularly interspaced short palindromic repeats (CRISPR) Cas 12a for signal amplification. Firstly, COF-367 NSs functionalized with gold nanoparticles (AuNPs) have been synthesized for the modification of the working electrode, thus the proposed sensor can show highly improved electrochemical performance. Secondly, by utilizing the trans-cleavage activity of Cas12a, this sensor can achieve very high sensitivity for the detection of PD-L1(+) exosomes. With such design, the biosensor can have a linear range from 1.2 x 10(2 )to 1.2 x 10(7) particles/mu L with a detection limit of 38 particles/mu L. Moreover, this sensor can be employed to analyze non-small cell lung cancer (NSCLC) patient serum samples, and successfully identify NSCLC patients, demonstrating the great potential in clinical applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据